Multiple functions and essential roles of nuclear receptor coactivators of bHLH-PAS family

Endocrine Regulations

Volumn 50, Issue 3, 2016, Pages 165-181

  Pecenova, L ^a   Farkas, Robert ^a  

^a INSTITUTE OF EXPERIMENTAL ENDOCRINOLOGY   (Slovakia)

Author keywords

BHLH PAS family; Coactivators; Nuclear receptors

Indexed keywords

ANDROGEN RECEPTOR; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; COLECALCIFEROL RECEPTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; ECDYSONE RECEPTOR; ESTROGEN RECEPTOR; FARNESOID X RECEPTOR; GLUCOCORTICOID RECEPTOR; GONADORELIN; HISTONE ACETYLTRANSFERASE; HISTONE ACETYLTRANSFERASE PCAF; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIVER X RECEPTOR; MINERALOCORTICOID RECEPTOR; NUCLEAR RECEPTOR COACTIVATOR; NUCLEAR RECEPTOR COACTIVATOR 2; PEPTIDES AND PROTEINS; PERIOD ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR PROTEIN SINGLE MINDED PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PROGESTERONE RECEPTOR; RETINOIC ACID RECEPTOR; RETINOID X RECEPTOR; STAT6 PROTEIN; STEROID RECEPTOR COACTIVATOR 1; THYROID HORMONE RECEPTOR; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; LIGAND; PROTEIN BINDING; STEROID RECEPTOR; TRANSCRIPTION FACTOR ARNTL;

ACUTE MYELOBLASTIC LEUKEMIA; ACUTE PHASE RESPONSE; ARTICLE; ENZYME ACTIVITY; EPITHELIAL MESENCHYMAL TRANSITION; GENETIC TRANSCRIPTION; HUMAN; NEGATIVE FEEDBACK; NONHUMAN; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN STRUCTURE; SIGNAL TRANSDUCTION; X RAY CRYSTALLOGRAPHY; ANIMAL; CHEMISTRY; METABOLISM; MOLECULAR MODEL; PROTEIN DOMAIN;

ANIMALS; ARNTL TRANSCRIPTION FACTORS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; HUMANS; LIGANDS; MODELS, MOLECULAR; NUCLEAR RECEPTOR COACTIVATORS; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN INTERACTION DOMAINS AND MOTIFS; RECEPTORS, STEROID; SIGNAL TRANSDUCTION;

EID: 84983444353     PISSN: 12100668     EISSN: 13360329     Source Type: Journal    
DOI: 10.1515/enr-2016-0019     Document Type: Article

References (146)

1. An BS, Selva DM, Hammond GL, Rivero-Muller A, Rahman N, Leung PC. Steroid receptor coactivator-3 is required for progesterone receptor trans-activation of target genes in response to gonadotropin-releasing hormone treatment of pituitary cells. J Biol Chem 281, 20817-20824, 2006.
2. Awais M, Sato M, Umezawa Y. Imaging of selective nuclear receptor modulator-induced conformational changes in the nuclear receptor to allow interaction with coactivator and corepressor proteins in living cells. Chembiochem 8, 737-743, 2007.
3. Beischlag TV, Luis Morales J, Hollingshead BD, Perdew GH. The aryl hydrocarbon receptor complex and the control of gene expression. Crit Rev Eukaryot Gene Expr 18, 207-250, 2008.
4. Bisson WH, Cheltsov AV, Bruey-Sedano N, Lin B, Chen J, Goldberger N, May LT, Christopoulos A, Dalton JT, Sexton PM, Zhang XK, Abagyan R. Discovery of antiandrogen activity of nonsteroidal scaffolds of marketed drugs. Proc Natl Acad Sci USA 104, 11927-11932, 2007.
5. Black JC, Choi JE, Lombardo SR, Carey M. A mechanism for coordinating chromatin modification and preinitiation complex assembly. Mol Cell 23, 809-818, 2006.
6. Buhr ED, Takahashi JS. Molecular components of the mammalian circadian clock. In: Handbook of Experimental Pharmacology (Ed. A Kramer, M Merrow), 217, 3-27, 2013.
7. Buzon V, Carbo LR, Estruch SB, Fletterick RJ, Estebanez-Perpina E. A conserved surface on the ligand binding domain of nuclear receptors for allosteric control. Mol Cell Endocrinol 348, 394-402, 2012.
8. Carlsson P, Koehler KF, Nilsson L. Glucocorticoid receptor point mutation V571M facilitates coactivator and ligand binding by structural rearrangement and stabilization. Mol Endocrinol 19, 1960-1977, 2005.
9. Chang AK, Wu H. The role of AIB1 in breast cancer. Oncol Lett 4, 588-594, 2012.
10. Chaudhary J, Skinner MK. Basic helix-loop-helix proteins can act at the E-box within the serum response element of the c-fos promoter to influence hormone-induced promoter activation in Sertoli cells. Mol Endocrinol 13, 774-786, 1999.
11. Chen JD, Evans RM. A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 377, 454-457, 1995.
12. Chopra AR, Kommagani R, Saha P, Louet JF, Salazar C, Song J, Jeong J, Finegold M, Viollet B, DeMayo F, Chan L, Moore DD, O’Malley BW. Cellular energy depletion resets whole-body energy by promoting coactivatormediated dietary fuel absorption. Cell Metab 13, 35-43, 2011.
13. Costantino G, Entrena-Guadix A, Macchiarulo A, Gioiello A, Pellicciari R. Molecular dynamics simulation of the ligand binding domain of farnesoid X receptor. Insights into helix-12 stability and coactivator peptide stabilization in response to agonist binding. J Med Chem 48, 3251-3259, 2005.
14. Darimont BD. Finding specificity within a conserved interaction site. Chem Biol 10, 675-676, 2003.
15. Dasgupta S, Lonard DM, O’Malley BW. Nuclear receptor coactivators: master regulators of human health and disease. Annu Rev Med 65, 279-292, 2014.
16. Davis JN, Williams BJ, Herron JT, Galiano FJ, Meyers S. ETO-2, a new member of the ETO-family of nuclear proteins. Oncogene 18, 1375-1383, 1999.
17. Demizu Y, Nagoya S, Shirakawa M, Kawamura M, Yamagata N, Sato Y, Doi M, Kurihara M. Development of stapled short helical peptides capable of inhibiting vitamin D receptor (VDR)-coactivator interactions. Bioorg Med Chem Lett 23, 4292-4296, 2013.
18. Ding L, Yang L, Wang Z, Huang W. Bile acid nuclear receptor FXR and digestive system diseases. Acta Pharm Sin B5 135-144, 2015.
19. D’Rozario M, Zhang T, Waddell EA, Zhang Y, Sahin C, Sharoni M, Hu T, Nayal M, Kutty K, Liebl F, Hu W, Marenda DR. Type I bHLH Proteins Daughterless and Tcf4 Restrict Neurite Branching and Synapse Formation by Repressing Neurexin in Postmitotic Neurons. Cell Rep 15, 386-397, 2016.
20. Dutertre M, Smith CL. Ligand-independent interactions of p160/steroid receptor coactivators and CREB-binding protein (CBP) with estrogen receptor-alpha: regulation by phosphorylation sites in the A/B region depends on other receptor domains. Mol Endocrinol 17, 1296-1314, 2003.
21. Elhaji YA, Stoica I, Dennis S, Purisima EO, Lumbroso R, Beitel LK, Trifiro MA. Impaired helix 12 dynamics due to proline 892 substitutions in the androgen receptor are associated with complete androgen insensitivity. Hum Mol Genet 15, 921-31, 2006.
22. Endler A, Chen L, Shibasaki F. Coactivator recruitment of AhR/ARNT1. Int J Mol Sci 15, 11100-11110, 2014.
23. Evans RM. The steroid and thyroid hormone receptor superfamily. Science 240, 889-895, 1988.
24. Farah MH, Olson JM, Sucic HB, Hume RI, Tapscott SJ, Turner DL. Generation of neurons by transient expression of neural bHLH proteins in mammalian cells. Development 127, 693-702, 2000.
25. Feng Q, Yi P, Wong J, O’Malley BW. Signaling within a coactivator complex: methylation of SRC-3/AIB1 is a molecular switch for complex disassembly. Mol Cell Biol 26, 7846-7857, 2006.
26. Fidelak J, Ferrer S, Oberlin M, Moras D, Dejaegere A, Stote RH. Dynamic correlation networks in human peroxisome proliferator-activated receptor-γ nuclear receptor protein. Eur Biophys J 39, 1503-1512, 2010.
27. Gallastegui N, Mackinnon JA, Fletterick RJ, Estebanez-Perpina E. Advances in our structural understanding of orphan nuclear receptors. Trends Biochem Sci 40, 25-35, 2015.
28. Gehin M, Mark M, Dennefeld C, Dierich A, Gronemeyer H, Chambon P. The function of TIF2/GRIP1 in mouse reproduction is distinct from those of SRC-1 and p/CIP. Mol Cell Biol 22, 5923-5937, 2002.
29. Gupte R, Muse GW, Chinenov Y, Adelman K, Rogatsky I. Glucocorticoid receptor represses proinflammatory genes at distinct steps of the transcription cycle. Proc Natl Acad Sci USA 110, 14616-14621, 2013.
30. Han SJ, Jung SY, Malovannaya A, Kim T, Lanz RB, Qin J, O’Malley BW. A scoring system for the follow up study of nuclear receptor coactivator complexes. Nucl Recept Signal 4, e014, 2006.
31. Han SJ, Hawkins SM, Begum K, Jung SY, Kovanci E, Qin J, Lydon JP, DeMayo FJ, O‘Malley BW. A new isoform of steroid receptor coactivator-1 is crucial for pathogenic progression of endometriosis. Nature Med 18, 1102-1111, 2012.
32. Harms MJ, Eick GN, Goswami D, Colucci JK, Griffin PR, Ortlund EA, Thornton JW. Biophysical mechanisms for large-effect mutations in the evolution of steroid hormone receptors. Proc Natl Acad Sci USA 110, 11475-11480, 2013.
33. He B, Kemppainen JA, Wilson EM. FXXLF and WXXLF sequences mediate the NH2-terminal interaction with the ligand binding domain of the androgen receptor. J Biol Chem 275, 22986-22994, 2000.
34. Hefti MH, Françoijs KJ, de Vries SC, Dixon R, Vervoort J. The PAS fold. A redefinition of the PAS domain based upon structural prediction. Eur J Biochem 27, 1198-208, 2004.
35. Heldin CH, Lu B, Evans R, Gutkind JS. Signals and Receptors. Cold Spring Harb Perspect Biol 8, 2016.
36. Hjalt T. Basic helix-loop-helix proteins expressed during early embryonic organogenesis. Int Rev Cytol 236, 251-280, 2004.
37. Hong H, Kohli K, Garabedian MJ, Stallcup MR. GRIP1, a transcriptional coactivator for the AF-2 transactivation domain of steroid, thyroid, retinoid, and vitamin D receptors. Mol Cell Biol May 17, 2735-2744, 1997.
38. Hsieh HT, Wang CH, Wu ML, Yang FM, Tai YC, Hu MC. PIASy inhibits LRH-1-dependent CYP11A1 expression by competing for SRC-1 binding. Biochem J 419, 201-209, 2009.
39. Hsu CL, Chen YL, Yeh S, Ting HJ, Hu YC, Lin H, Wang X, Chang C. The use of phage display technique for the isolation of androgen receptor interacting peptides with (F/W)XXL(F/W) and FXXLY new signature motifs. J Biol Chem 278, 23691-23698, 2003.
40. Huang N, Chelliah Y, Shan Y, Taylor CA, Yoo SH, Partch C, Green CB, Zhang H, Takahashi JS. Crystal structure of the heterodimeric CLOCK:BMAL1 transcriptional activator complex. Science 337, 189-194, 2012.
41. Hughes TS, Chalmers MJ, Novick S, Kuruvilla DS, Chang MR, Kamenecka TM, Rance M, Johnson BA, Burris TP, Griffin PR, Kojetin DJ. Ligand and receptor dynamics contribute to the mechanism of graded PPARγ agonism. Structure 20, 139-150, 2012.
42. Jasuja R, Ulloor J, Yengo CM, Choong K, Istomin AY, Livesay DR, Jacobs DJ, Swerdloff RS, Miksovska J, Larsen RW, Bhasin S. Kinetic and thermodynamic characterization of dihydrotestosterone-induced conformational perturbations in androgen receptor ligand-binding domain. Mol Endocrinol 23, 1231-1241, 2009.
43. Jones S. An overview of the basic helix-loop-helix proteins. Genome Biol 5, 226, 2004.
44. Jung SY, Malovannaya A, Wei J, O’Malley BW, Qin J. Proteomic analysis of steady-state nuclear hormone receptor coactivator complexes. Mol Endocrinol 19, 2451-2465, 2005.
45. Kastner P, Mark M, Chambon P. Nonsteroid nuclear receptors: what are genetic studies telling us about their role in real life? Cell 83, 859-869, 1995.
46. Kim MS, Sweeney TR, Shigenaga JK, Chui LG, Moser A, Grunfeld C, Feingold KR. Tumor necrosis factor and interleukin 1 decrease RXRalpha, PPARalpha, PPARgamma, LXRalpha, and the coactivators SRC-1, PGC- 1alpha, and PGC-1beta in liver cells. Metabolism 56, 267-279, 2007.
47. King-Jones K, Thummel CS. Nuclear receptors - a perspective from Drosophila. Nature Rev Genet 6, 311-323, 2005.
48. Kitabayashi I, Ida K, Morohoshi F, Yokoyama A, Mitsuhashi N, Shimizu K, Nomura N, Hayashi Y, Ohki M. The AML1-MTG8 leukemic fusion protein forms a complex with a novel member of the MTG8(ETO/CDR) family, MTGR1. Mol Cell Biol 18, 846-858, 1998.
49. Klinge CM, Jernigan SC, Mattingly KA, Risinger KE, Zhang J. Estrogen response element-dependent regulation of transcriptional activation of estrogen receptors alpha and beta by coactivators and corepressors. J Mol Endocrinol 33, 387-410, 2004.
50. Kokubo T, Gong DW, Roeder RG, Horikoshi M, Nakatani Y. The Drosophila 110-kDa transcription factor TFIID subunit directly interacts with the N-terminal region of the 230-kDa subunit. Proc Natl Acad Sci USA 90, 5896-5900, 1993.
51. Laffitte BA, Kast HR, Nguyen CM, Zavacki AM, Moore DD, Edwards PA. Identification of the DNA binding specificity and potential target genes for the farnesoid X-activated receptor. J Biol Chem 275, 10638-10647, 2000.
52. Lee YH, Coonrod SA, Kraus WL, Jelinek MA, Stallcup MR. Regulation of coactivator complex assembly and function by protein arginine methylation and demethylimination. Proc Natl Acad Sci USA 102, 3611-3616, 2005.
53. Leo C, Chen JD. The SRC family of nuclear receptor coactivators. Gene 245, 1-11, 2000.
54. Li H, Chen JD. The receptor-associated coactivator 3 activates transcription through CREB-binding protein recruitment and autoregulation. J Biol Chem 273, 5948-5954, 1998.
55. Licht JD. AML1 and the AML1-ETO fusion protein in the pathogenesis of t(8;21) AML. Oncogene 20, 5660-5679, 2001.
56. Litterst CM, Pfitzner E. An LxxLL motif in the transactivation domain of STAT6 mediates recruitment of NCoA-1/ SRC-1. J Biol Chem 277, 36052-36060, 2002.
57. Littlewood TD, Evan GI. Transcription factors 2: helix-loop-helix. Protein Profile 1, 635-709, 1994.
58. Liu J, Zhou B, Yan M, Huang R, Wang Y, He Z, Yang Y, Dai C, Wang Y, Zhang F, Zhai Q. CLOCK and BMAL1 regulate muscle insulin sensitivity via SIRT1 in male mice. Endocrinology, en20152027, 2016. [Epub ahead of print]
59. Loinder K, Soderstrom M. Functional analyses of an LXXLL motif in nuclear receptor corepressor (N-CoR). J Steroid Biochem Mol Biol 91, 191-196, 2004.
60. Ma X, Xu L, Wang S, Cui B, Li X, Xu J, Ning G. Deletion of steroid receptor coactivator-3 gene ameliorates hepatic steatosis. J Hepatol 55, 445-452, 2011.
61. Mackinnon JA, Gallastegui N, Osguthorpe DJ, Hagler AT, Estebanez-Perpina E. Allosteric mechanisms of nuclear receptors: insights from computational simulations. Mol Cell Endocrinol 393, 75-82, 2014.
62. Madak-Erdogan Z, Katzenellenbogen BS. Aryl hydrocarbon receptor modulation of estrogen receptor α-mediated gene regulation by a multimeric chromatin complex involving the two receptors and the coregulator RIP140. Toxicol Sci 125, 401-411, 2012.
63. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P, Evans RM. The nuclear receptor superfamily: the second decade. Cell 83, 835-839, 1995.
64. Mascrez B, Ghyselinck NB, Watanabe M, Annicotte JS, Chambon P, Auwerx J, Mark M. Ligand-dependent contribution of RXRbeta to cholesterol homeostasis in Sertoli cells. EMBO Rep 5, 285-290, 2004.
65. Matthews J, Wihlen B, Thomsen J, Gustafsson JA. Aryl hydrocarbon receptor-mediated transcription: ligand-dependent recruitment of estrogen receptor alpha to 2,3,7,8-tetrachlorodibenzo-p-dioxin-responsive promoters. Mol Cell Biol 25, 5317-5328, 2005.
66. Maywood ES, Chesham JE, Smyllie NJ, Hastings MH. The Tau mutation of casein kinase 1ε sets the period of the mammalian pacemaker via regulation of Period1 or Period2 clock proteins. J Biol Rhyth 29, 110-118, 2014.
67. Metivier R, Penot G, Flouriot G, Pakdel F. Synergism between ERalpha transactivation function 1 (AF-1) and AF-2 mediated by steroid receptor coactivator protein-1: requirement for the AF-1 alpha-helical core and for a direct interaction between the N- and C-terminal domains. Mol Endocrinol 15, 1953-1970, 2001.
68. Mimura J, Fujii-Kuriyama Y. Functional role of AhR in the expression of toxic effects by TCDD. Biochim Biophys Acta 1619, 263-268, 2003.
69. Mita Y, Dodo K, Noguchi-Yachide T, Miyachi H, Makishima M, Hashimoto Y, Ishikawa M. LXXLL peptide mimetics as inhibitors of the interaction of vitamin D receptor with coactivators. Bioorg Med Chem Lett 20, 1712-1717, 2010.
70. Molnar F, Matilainen M, Carlberg C. Structural determinants of the agonist-independent association of human peroxisome proliferator-activated receptors with coactivators. J Biol Chem 280, 26543-2656, 2005.
71. Morishita Y, Miura D, Kida S. PI3K regulates BMAL1/CLOCK-mediated circadian transcription from the Dbp promoter. Biosci Biotechnol Biochem 80, 1131-1140, 2016.
72. Mouchon A, Delmotte MH, Formstecher P, Lefebvre P. Allosteric regulation of the discriminative responsiveness of retinoic acid receptor to natural and synthetic ligands by retinoid X receptor and DNA. Mol Cell Biol 19, 3073-3085, 1999.
73. Murphy KA, Quadro L, White LA. The intersection between the aryl hydrocarbon receptor (AhR)- and retinoic acidsignaling pathways. Vitam Horm 75, 33-67, 2007.
74. Musille PM, Pathak MC, Lauer JL, Hudson WH, Griffin PR, Ortlund EA. Antidiabetic phospholipid-nuclear receptor complex reveals the mechanism for phospholipid-driven gene regulation. Nat Struct Mol Biol 19, 532-537, 2012.
75. Nagy L, Kao HY, Love JD, Li C, Banayo E, Gooch JT, Krishna V, Chatterjee K, Evans RM, Schwabe JW. Mechanism of corepressor binding and release from nuclear hormone receptors. Genes Dev 13, 3209-3216, 1999.
76. Nguyen TA, Hoivik D, Lee JE, Safe S. Interactions of nuclear receptor coactivator/corepressor proteins with the aryl hydrocarbon receptor complex. Arch Biochem Biophys 367, 250-257, 1999.
77. Norman AW. Identification of a unique nuclear receptor for 9-cis retinoic acid. Nutr Rev 50, 230-231, 1992.
78. O’Malley BW. Coregulators: from whence came these ‘master genes’. Mol Endocrinol 21, 1009-1013, 2007.
79. Onate SA, Tsai SY, Tsai MJ, O’Malley BW. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270, 1354-1357, 1995.
80. Osborne CK, Bardou V, Hopp TA, Chamness GC, Hilsenbeck SG, Fuqua SA, Wong J, Allred DC, Clark GM, Schiff R. Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer. J Natl Cancer Inst 95, 353-361, 2003.
81. Osguthorpe DJ, Hagler AT. Mechanism of androgen receptor antagonism by bicalutamide in the treatment of prostate cancer. Biochemistry 50, 4105-4113, 2011.
82. Osguthorpe DJ, Sherman W, Hagler AT. Generation of receptor structural ensembles for virtual screening using binding site shape analysis and clustering. Chem Biol Drug Des 80, 182-193, 2012.
83. Pappa KI, Gazouli M, Anastasiou E, Iliodromiti Z, Antsaklis A, Anagnou NP. The major circadian pacemaker ARNT-like protein-1 (BMAL1) is associated with susceptibility to gestational diabetes mellitus. Diabetes Res Clin Pract 99, 151-157, 2013.
84. Paramanik V, Thakur MK. AIB1 shows variation in interaction with ERβTAD and expression as a function of age in mouse brain. Biogerontology 12, 321-328, 2011.
85. Parker MG, White R. Nuclear receptors spring into action. Nat Struct Biol 3, 113-115, 1996.
86. Percharde M, Lavial F, Ng JH, Kumar V, Tomaz RA, Martin N, Yeo JC, Gil J, Prabhakar S, Ng HH, Parker MG, Azuara V. Ncoa3 functions as an essential Esrrb coactivator to sustain embryonic stem cell self-renewal and reprogramming. Genes Dev 26, 2286-2298, 2012.
87. Pogenberg V, Guichou JF, Vivat-Hannah V, Kammerer S, Perez E, Germain P, de Lera AR, Gronemeyer H, Royer CA, Bourguet W. Characterization of the interaction between retinoic acid receptor/retinoid X receptor (RAR/ RXR) heterodimers and transcriptional coactivators through structural and fluorescence anisotropy studies. J Biol Chem 280, 1625-1633, 2005.
88. Ponting CP, Aravind L. PAS: a multi-functional domain family comes to light. Curr Biol 7, R674-R677, 1997.
89. Presman DM, Alvarez LD, Levi V, Eduardo S, Digman MA, Marti MA, Veleiro AS, Burton G, Pecci A. Insights on glucocorticoid receptor activity modulation through the binding of rigid steroids. PLoS One 5, e13279, 2010.
90. Pugh BF. HATs off to PIC assembly. Molec Cell 23, 776-777, 2006.
91. Qin L, Liu Z, Chen H, Xu J. The steroid receptor coactivator-1 regulates twist expression and promotes breast cancer metastasis. Cancer Res 69, 3819-3827, 2009.
92. Quong MW, Romanow WJ, Murre C. E protein function in lymphocyte development. Annu Rev Immunol 20, 301-322, 2002.
93. Rachez C, Gamble M, Chang CP, Atkins GB, Lazar MA, Freedman LP. The DRIP complex and SRC-1/p160 coactivators share similar nuclear receptor binding determinants but constitute functionally distinct complexes. Mol Cell Biol 20, 2718-2726, 2000.
94. Radhakrishnan I, Perez-Alvarado GC, Parker D, Dyson HJ, Montminy MR, Wright PE. Solution structure of the KIX domain of CBP bound to the transactivation domain of CREB: a model for activator:coactivator interactions. Cell 91, 741-752, 1997.
95. Razeto A, Ramakrishnan V, Litterst CM, Giller K, Griesinger C, Carlomagno T, Lakomek N, Heimburg T, Lodrini M, Pfitzner E, Becker S. Structure of the NCoA-1/SRC-1 PAS-B domain bound to the LXXLL motif of the STAT6 transactivation domain. J Mol Biol 336, 319-329, 2004.
96. Richards J, Diaz AN, Gumz ML. Clock genes in hypertension: novel insights from rodent models. Blood Pres Monitor 19, 249-254, 2014.
97. Rushing SR, Denison MS. The silencing mediator of retinoic acid and thyroid hormone receptors can interact with the aryl hydrocarbon (Ah) receptor but fails to repress Ah receptor-dependent gene expression. Arch Biochem Biophys 403, 189-201, 2002.
98. Ruegg J, Swedenborg E, Wahlstrom D, Escande A, Balaguer P, Pettersson K, Pongratz I. The transcription factor aryl hydrocarbon receptor nuclear translocator functions as an estrogen receptor beta-selective coactivator, and its recruitment to alternative pathways mediates antiestrogenic effects of dioxin. Mol Endocrinol 22, 304-316, 2008.
99. Sachs LM, Shi YB. Targeted chromatin binding and histone acetylation in vivo by thyroid hormone receptor during amphibian development. Proc Natl Acad Sci USA 97, 13138-13143, 2000.
100. Sachs LM, Amano T, Rouse N, Shi YB. Involvement of histone deacetylase at two distinct steps in gene regulation during intestinal development in Xenopus laevis. Dev Dyn 222, 280-291, 2001.
101. Sheppard HM, Harries JC, Hussain S, Bevan C, Heery DM. Analysis of the steroid receptor coactivator 1 (SRC1)- CREB binding protein interaction interface and its importance for the function of SRC1. Mol Cell Biol 21, 39-50, 2001.
102. Shibata H, Spencer TE, Onate SA, Jenster G, Tsai SY, Tsai MJ, O’Malley BW. Role of co-activators and co-repressors in the mechanism of steroid/thyroid receptor action. Recent Prog Horm Res 52, 141-64, 1997.
103. Shiota M, Yokomizo A, Tada Y, Inokuchi J, Tatsugami K, Kuroiwa K, Uchiumi T, Fujimoto N, Seki N, Naito S. Peroxisome proliferator-activated receptor γ coactivator-1α interacts with the androgen receptor (AR) and promotes prostate cancer cell growth by activating the AR. Mol Endocrinol 24, 114-127, 2009.
104. Son YL, Lee YC. Molecular determinants of the interactions between SRC-1 and LXR/RXR heterodimers. FEBS Lett 584, 3862-3866, 2010.
105. Souza PC, Barra GB, Velasco LF, Ribeiro IC, Simeoni LA, Togashi M, Webb P, Neves FA, Skaf MS, Martinez L, Polikarpov I. Helix 12 dynamics and thyroid hormone receptor activity: experimental and molecular dynamics studies of Ile280 mutants. J Mol Biol 412, 882-893, 2011.
106. Spencer TE, Jenster G, Burcin MM, Allis CD, Zhou J, Mizzen CA, McKenna NJ, Onate SA, Tsai SY, Tsai MJ, O’Malley BW. Steroid receptor coactivator-1 is a histone acetyltransferase. Nature 389, 194-198, 1997.
107. Stashi E, Wang L, Mani SK, York B, O’Malley BW. Research resource: loss of the steroid receptor coactivators confers neurobehavioral consequences. Mol Endocrinol 27, 1776-1787, 2013.
108. Stashi E, York B, O’Malley BW. Steroid receptor coactivators: servants and masters for control of systems metabolism. Trends Endocrinol Metab 25, 337-347, 2014.
109. Sterner DE, Berger SL. Acetylation of histones and transcription-related factors. Microbiol Mol Biol Rev 64, 435-459, 2000.
110. Taylor BS, Schultz N, Hieronymus H, Gopalan A, Xiao Y, Carver BS, Arora VK, Kaushik P, Cerami E, Reva B, Antipin Y, Mitsiades N, Landers T, Dolgalev I, Major JE, Wilson M, Socci ND, Lash AE, Heguy A, Eastham JA, Scher HI, Reuter VE, Scardino PT, Sander C, Sawyers CL, Gerald WL. Integrative genomic profiling of human prostate cancer. Cancer Cell 18, 11-22, 2010.
111. Torchia J, Rose DW, Inostroza J, Kamei Y, Westin S, Glass CK, Rosenfeld MG. The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function. Nature 387, 677-684, 1997.
112. Tyteca S, Legube G, Trouche D. To die or not to die: a HAT trick. Mol Cell 24, 807-808, 2006.
113. Uhlenhaut NH, Barish GD, Yu RT, Downes M, Karunasiri M, Liddle C, Schwalie P, Hubner N, Evans RM. Insights into negative regulation by the glucocorticoid receptor from genome-wide profiling of inflammatory cistromes. Mol Cell 49, 158-171, 2013.
114. Utley RT, Ikeda K, Grant PA, Cote J, Steger DJ, Eberharter A, John S, Workman JL. Transcriptional activators direct histone acetyltransferase complexes to nucleosomes. Nature 394, 498-502, 1998.
115. van de Wijngaart DJ, van Royen ME, Hersmus R, Pike AC, Houtsmuller AB, Jenster G, Trapman J, Dubbink HJ. Novel FXXFF and FXXMF motifs in androgen receptor cofactors mediate high affinity and specific interactions with the ligand-binding domain. J Biol Chem 281, 19407-19416, 2006.
116. van de Wijngaart DJ, Dubbink HJ, van Royen ME, Trapman J, Jenster G. Androgen receptor coregulators: recruitment via the coactivator binding groove. Mol Cell Endocrinol 352, 57-69, 2012.
117. Vo N, Goodman RH. CREB-binding protein and p300 in transcriptional regulation. J Biol Chem 276, 13505-13508, 2001.
118. Walfish PG, Yoganathan T, Yang YF, Hong H, Butt TR, Stallcup MR. Yeast hormone response element assays detect and characterize GRIP1 coactivator-dependent activation of transcription by thyroid and retinoid nuclear receptors. Proc Natl Acad Sci USA 94, 3697-3702, 1997.
119. Walsh CA, Qin L, Tien JC, Young LS, Xu J. The function of steroid receptor coactivator-1 in normal tissues and cancer. Int J Biol Sci 8, 470-485, 2012.
120. Wang Y. Downregulation of liver X receptor in mouse kidney and HK-2 proximal tubular cells by LPS and cytokines. J Lipid Res 46, 2377-2387, 2005.
121. Wang Z, Burke PA. Modulation of hepatocyte nuclear factor-4alpha function by the peroxisome-proliferator-activated receptor-gamma co-activator-1alpha in the acute-phase response. Biochem J 415, 289-296, 2008.
122. Wang Y, Kumar N, Crumbley C, Griffin PR, Burris TP. A second class of nuclear receptors for oxysterols: Regulation of RORalpha and RORgamma activity by 24S-hydroxycholesterol (cerebrosterol). Biochim Biophys Acta 1801, 917-923, 2010.
123. Wang Y, Lonard DM, Yu Y, Chow DC, Palzkill TG, O’Malley BW. Small molecule inhibition of the steroid receptor coactivators, SRC-3 and SRC-1. Molec Endocrinol 25, 2041-2053, 2011.
124. Wang Z, Wu Y, Li L, Su XD. Intermolecular recognition revealed by the complex structure of human CLOCKBMAL1 basic helix-loop-helix domains with E-box DNA”. Cell Res 23, 213-224, 2013.
125. Wang Y, Lonard DM, Yu Y, Chow DC, Palzkill TG, Wang J, Qi R, Matzuk AJ, Song X, Madoux F, Hodder P, Chase P, Griffin PR, Zhou S, Liao L, Xu J, O’Malley BW. Bufalin is a potent small-molecule inhibitor of the steroid receptor coactivators SRC-3 and SRC-1. Cancer Res 74, 1506-1517, 2014.
126. Weber D, Wiese C, Gessler M. Hey bHLH transcription factors. Curr Top Dev Biol 110, 285-315, 2014.
127. Widerak M, Ghoneim C, Dumontier MF, Quesne M, Corvol MT, Savouret JF. The aryl hydrocarbon receptor activates the retinoic acid receptor alpha through SMRT antagonism. Biochimie 88, 387-397, 2006.
128. Wolf G. Cellular retinoic acid-binding protein II: a coactivator of the transactivation by the retinoic acid receptor complex RAR.RXR. Nutr Rev 58, 151-153, 2000.
129. Wu JH, Gottlieb B, Batist G, Sulea T, Purisima EO, Beitel LK, Trifiro M. Bridging structural biology and genetics by computational methods: an investigation into how the R774C mutation in the AR gene can result in complete androgen insensitivity syndrome. Hum Mutat 22, 465-475, 2003.
130. Wu RC, Qin J, Yi P, Wong J, Tsai SY, Tsai MJ, O’Malley BW. Selective phosphorylations of the SRC-3/AIB1 coactivator integrate genomic reponses to multiple cellular signaling pathways. Mol Cell 24, 937-949, 2004.
131. Wu RC, Feng Q, Lonard DM, O’Malley BW. SRC-3 coactivator functional lifetime is regulated by a phospho-dependent ubiquitin time clock. Cell 129, 1125-1140, 2007.
132. Wurtz JM, Bourguet W, Renaud JP, Vivat V, Chambon P, Moras D, Gronemeyer H. A canonical structure for the ligand-binding domain of nuclear receptors. Nat Struct Biol 3, 206, 1996.
133. Xiong W, Li J, Zhang E, Huang H. BMAL1 regulates transcription initiation and activates circadian clock gene expression in mammals. Biochem Biophys Res Commun 473, 1019-1025, 2016.
134. Xu J, Liao L, Ning G, Yoshida-Komiya H, Deng C, O‘Malley BW. The steroid receptor coactivator SRC-3 (p/CIP/RAC3/ AIB1/ACTR/TRAM-1) is required for normal growth, puberty, female reproductive function, and mammary gland development. Proc Natl Acad Sci USA 97, 6379-6384, 2000.
135. Xu J, Li Q. Review of the in vivo functions of the p160 steroid receptor coactivator family. Mol Endocrinol 17, 1681-1692, 2003.
136. Xu J, Wu RC, O’Malley BW. Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) family. Nature Rev Cancer 9, 615-630, 2009.
137. Xu X, Yang W, Wang X, Li Y, Wang Y, Ai C. Dynamic communication between androgen and coactivator: mutually induced conformational perturbations in androgen receptor ligand-binding domain. Proteins 79, 1154-1171, 2011.
138. Yamamoto KR. Steroid receptor regulated transcription of specific genes and gene networks. Annu Rev Genet 19, 209-215, 1985.
139. Yan F, Yu Y, Chow DC, Palzkill T, Madoux F, Hodder P, Chase P, Griffin PR, O’Malley BW, Lonard DM. Identification of verrucarin a as a potent and selective steroid receptor coactivator-3 small molecule inhibitor. PLoS One 9, e95243, 2014.
140. York B, O’Malley BW. Steroid receptor coactivator (SRC) family: masters of systems biology. J Biol Chem 285, 38743-38750, 2010.
141. Zakharov MN, Pillai BK, Bhasin S, Ulloor J, Istomin AY, Guo C, Godzik A, Kumar R, Jasuja R. Dynamics of coregulator- induced conformational perturbations in androgen receptor ligand binding domain. Mol Cell Endocrinol 341, 1-8, 2011.
142. Zelenko Z, Aghajanova L, Irwin JC, Giudice LC. Nuclear receptor, coregulator signaling, and chromatin remodeling pathways suggest involvement of the epigenome in the steroid hormone response of endometrium and abnormalities in endometriosis. Reprod Sci 19, 152-162, 2012.
143. Zhang J, Kalkum M, Yamamura S, Chait BT, Roeder RG. E protein silencing by the leukemogenic AML1-ETO fusion protein. Science 305, 1286-1289, 2004.
144. Zhou G, Cummings R, Li Y, Mitra S, Wilkinson HA, Elbrecht A, Hermes JD, Schaeffer JM, Smith RG, Moller DE. Nuclear receptors have distinct affinities for coactivators: characterization by fluorescence resonance energy transfer. Mol Endocrinol 12, 1594-604, 1998.
145. Zhu B, Gates LA, Stashi E, Dasgupta S, Gonzales N, Dean A, Dacso CC, York B, O’Malley BW. Coactivator-Dependent Oscillation of Chromatin Accessibility Dictates Circadian Gene Amplitude via REV-ERB Loading. Mol Cell 60, 769-783, 2015.
146. Zor T, De Guzman RN, Dyson HJ, Wright PE. Solution structure of the KIX domain of CBP bound to the transactivation domain of c-Myb. J Mol Biol 337, 521-534, 2004.